Walleye Capital LLC Relmada Therapeutics, Inc. Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$2.24 - $4.76 $473,092 - $1.01 Million	-211,202 Reduced 44.59%	262,481 $593,000
Q4 2022 Feb 14, 2023	BUY	$2.17 - $35.84 $1.03 Million - $17 Million	473,683 New	473,683 $1.65 Million
Q2 2022 Aug 08, 2022	SELL	$16.5 - $30.34 $277,348 - $509,985	-16,809 Reduced 13.64%	106,420 $2.02 Million
Q1 2022 May 16, 2022	BUY	$16.72 - $26.99 $1.71 Million - $2.76 Million	102,410 Added 491.91%	123,229 $3.33 Million
Q4 2021 Mar 03, 2022	BUY	$16.93 - $26.82 $352,465 - $558,365	20,819 New	20,819 $469,000

12.3M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $10.9M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.